Smooth muscle actin inhibitors constitute a distinct class of chemical compounds meticulously crafted to selectively target and impede the activity of smooth muscle actin, a protein of paramount importance in the intricate architecture of the cytoskeleton within smooth muscle cells. These specialized cells are strategically distributed throughout various organs and tissues, including the walls of blood vessels, the gastrointestinal tract, and the respiratory tract, where they orchestrate indispensable physiological processes such as blood vessel constriction and dilation, peristalsis, and other involuntary movements.
The nuanced functionality of smooth muscle actin inhibitors hinges on their precision targeting of the smooth muscle actin protein. These inhibitors exert their influence by impeding the polymerization of smooth muscle actin, thereby disrupting the formation of contractile filaments essential for the generation of force and contraction in smooth muscle cells. This targeted interference holds the key to reshaping the mechanical properties and contractility of smooth muscle cells, influencing their pivotal role in physiological processes. Ongoing research into smooth muscle actin inhibitors endeavors to unveil the intricate mechanisms governing their mode of action, striving to decode the implications these inhibitors might have in elucidating the complex regulation of smooth muscle function. The study of smooth muscle actin inhibitors stands as a testament to the scientific pursuit of unraveling the complexities inherent in muscle physiology and cellular dynamics. By delving into the subtle intricacies of how these inhibitors modulate the activity of smooth muscle actin, researchers contribute to a growing body of knowledge. This scientific inquiry enriches our understanding of the fundamental principles that govern cellular function, paving the way for a deeper appreciation of the dynamic interplay between molecular components within the realm of smooth muscle biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Disrupts actin polymerization by capping the growing end of actin filaments. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Binds to actin monomers, preventing their polymerization into filaments. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Enhances actin polymerization, potentially affecting smooth muscle actin. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $179.00 $307.00 $455.00 $924.00 $1689.00 | 7 | |
Inhibits myosin ATPase activity, leading to reduced muscle contractility. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
ROCK inhibitor that impacts actin cytoskeleton dynamics in smooth muscle. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $119.00 $447.00 | 28 | |
Inhibits calpain-mediated actin cleavage in smooth muscle cells. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $315.00 $1020.00 | 5 | |
Blocks Arp2/3 complex-mediated actin nucleation and branching. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
Inhibits formin-mediated actin nucleation and polymerization. | ||||||
Cytosporone B | 321661-62-5 | sc-252653 | 5 mg | $143.00 | 7 | |
Modulates actin dynamics in smooth muscle cells and affects cytoskeletal structure. | ||||||
CK-869 | 388592-44-7 | sc-507274 | 5 mg | $160.00 | ||
CK-869 disrupts actin filament assembly through inhibition of Arp2/3 complex. |